Global Anticoagulant Registry in the Field

Completed

Conditions studied: Atrial Fibrillation

In brief

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).

Key facts

Study ID

NCT01090362

Run by

Thrombosis Research Institute

People needed

57250

Starts

2009-12-21

Expected to finish

2020-05-18

Last updated by the study team

2021-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prospective Cohort
• Written informed consent
• Age 18 years and older
• New diagnosis of non-valvular atrial fibrillation (diagnosed within the last 6 weeks) with at least one additional risk factor for stroke and regardless of therapy.
• Retrospective validation cohort
• Written informed consent
• Age 18 years and older
• Diagnosis of non-valvular AF (diagnosed 6-24 months prior to enrolment) with at least one additional risk factor for stroke and regardless of therapy.

You may not qualify if…

• No further follow-up envisaged or possible within enrolling hospital or with associated family practitioner.
• Patients with transient AF secondary to a reversible cause.
• Patients recruited in controlled clinical trials.

Where it is running

• Prof. Samuel Goldhaber — Boston, Massachusetts, United States
• Dr Hector Luciardi, National Co-ordinating Investigator, National University of Tucuman — San Miguel de Tucumán, Argentina
• Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital — Melbourne, Australia
• Marianne Brodmann: National Co-ordinating Investigator, Medizinische Universität Graz — Graz, Austria
• Dr Frank Cools, National Co-ordinating Investigator, AZ Klina — Brasschaat, Belgium
• Dr Antonio Barretto, National Coordinating Investigator, Hospital Santa Marcelina, — São Paulo, Brazil
• Prof Stuart Connolly and Dr John Eikelboom, National Coodinating Investigators, Mc Master University — Hamilton, Canada
• Dr Ramon Corbalan, National Coordinating Investigator, Pontifica Universidad Catolica de Chile — Santiago, Chile
• Prof Zin-Cheng, National Coordinating Investigator, Peking Union Medical College & Chinese Academy Medical Sciences People Hospital — Beijing, China
• Dr Petr Jansky, National Coordinating Investigator, Cardiovaskular Center, Motol Univesity Hospital — Prague, Czechia
• Prof Joern Dalsgaard Nielsen, National Coordinating Investigator, Bispebjerg & Frederiksberg Hospitals — Frederiksberg, Denmark
• Dr. Hany Ragy, National Coordinating Investigator, Hayat Hospital — Cairo, Egypt
• Prof Pekka Raatikainen, National Coordinating Investigator, Univesrsity of Tampere — Tampere, Finland
• Prof. Jean-Yues LeHeuzey, National Coordinating Investigator, Hopital Europeen Georges Pompidou — Paris, France
• Prof Harald Darius, National oordinating Investigator, Vivantes Klinikum Neukölln — Berlin, Germany
• Dr Matyas Keltai, National Coordinating Investigator, Hungarian Institute of Cardiology — Budapest, Hungary
• Dr Sawney, National Coordinating Investigator, Sir Ganga Ram Hospital, New Delhi — Bangalore, India
• Profs Giancarlo Agnelli and Giuseppe Ambrosio, National Coordinating Investigators, University of Perugia — Perugia, Italy
• Professor Yukihiro Koretsune, National Coordinating Investigator, Osaka National Hospital — Osaka, Japan
• Dr Carlos Jerjes Sanchez Diaz, National Coordinating Investigator,Tecnologico de Monterrey — Monterrey, Mexico
• Professor Hugo ten Cate, National Coordinating Investigator, Cardiovascular Research Institute Maastricht — Maastricht, Netherlands
• Professor Dan Atar, National Coordinating Investigator, Oslo University Hospital — Oslo, Norway
• Prof Janina Stępińska, National Coordinating Investigator, Institute of Cardiology, Warsaw — Warsaw, Poland
• Professor Elizaveta Panchenko, National Coordinating Investigator, Cardiology Research and Production Center — Moscow, Russia
• Dr Toon Wei Lim, National Coordinating Investigator, National University Hospital — Singapore, Singapore

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.